BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10347218)

  • 1. The HMG-I(Y) A.T-hook peptide motif confers DNA-binding specificity to a structured chimeric protein.
    Banks GC; Mohr B; Reeves R
    J Biol Chem; 1999 Jun; 274(23):16536-44. PubMed ID: 10347218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y).
    Currie RA
    J Biol Chem; 1997 Dec; 272(49):30880-8. PubMed ID: 9388234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
    Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
    J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of conserved threonines by alanine residues in high mobility group protein HMG-I(Y): effect on DNA binding affinity.
    Siino JS; Nissen MS; Reeves R
    Biochem Biophys Res Commun; 1995 Feb; 207(2):497-507. PubMed ID: 7532403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo.
    Beckerbauer L; Tepe JJ; Cullison J; Reeves R; Williams RM
    Chem Biol; 2000 Oct; 7(10):805-12. PubMed ID: 11033083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y).
    Chin MT; Pellacani A; Wang H; Lin SS; Jain MK; Perrella MA; Lee ME
    J Biol Chem; 1998 Apr; 273(16):9755-60. PubMed ID: 9545312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-binding properties of the recombinant high-mobility-group-like AT-hook-containing region from human BRG1 protein.
    Singh M; D'Silva L; Holak TA
    Biol Chem; 2006; 387(10-11):1469-78. PubMed ID: 17081121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells.
    Klein-Hessling S; Schneider G; Heinfling A; Chuvpilo S; Serfling E
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15311-6. PubMed ID: 8986808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small region in HMG I(Y) is critical for cooperation with NF-kappaB on DNA.
    Zhang XM; Verdine GL
    J Biol Chem; 1999 Jul; 274(29):20235-43. PubMed ID: 10400641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1.
    Hill DA; Pedulla ML; Reeves R
    Nucleic Acids Res; 1999 May; 27(10):2135-44. PubMed ID: 10219086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein.
    Nissen MS; Langan TA; Reeves R
    J Biol Chem; 1991 Oct; 266(30):19945-52. PubMed ID: 1939057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions.
    Banks GC; Li Y; Reeves R
    Biochemistry; 2000 Jul; 39(28):8333-46. PubMed ID: 10889043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
    Yie J; Merika M; Munshi N; Chen G; Thanos D
    EMBO J; 1999 Jun; 18(11):3074-89. PubMed ID: 10357819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of the HMGI(Y) family of architectural transcription factors.
    Reeves R
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():803-9. PubMed ID: 11035986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 4-inducible phosphorylation of HMG-I(Y) is inhibited by rapamycin.
    Wang DZ; Ray P; Boothby M
    J Biol Chem; 1995 Sep; 270(39):22924-32. PubMed ID: 7559428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate structure influences binding of the non-histone protein HMG-I(Y) to free nucleosomal DNA.
    Reeves R; Wolffe AP
    Biochemistry; 1996 Apr; 35(15):5063-74. PubMed ID: 8664299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms.
    Du W; Maniatis T
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11318-22. PubMed ID: 7972056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology.
    Bagga R; Michalowski S; Sabnis R; Griffith JD; Emerson BM
    Nucleic Acids Res; 2000 Jul; 28(13):2541-50. PubMed ID: 10871404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the DNA-binding properties of the HMG-box domains of HMG1 and the sex-determining factor SRY.
    Teo SH; Grasser KD; Thomas JO
    Eur J Biochem; 1995 Jun; 230(3):943-50. PubMed ID: 7601157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4.
    van Houte LP; Chuprina VP; van der Wetering M; Boelens R; Kaptein R; Clevers H
    J Biol Chem; 1995 Dec; 270(51):30516-24. PubMed ID: 8530483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.